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ABSTRACT 
 
BACKGROUND:  Oral  squamous cell carcinoma (OSCC) results from 
the multistep accumulation of heterogenous genetic changes.  The poor 
prognosis of oral cancer is due to several reasons such as late stage 
diagnosis,  low response to current therapeutic strategies,  primary site 
recurrence, high rate of metastasis to regional lymph nodes etc. which 
has strongly recommended the need to improve the diagnostic 
capabilities. Assessing the tumor behaviour at the molecular level will  
help in initiating appropriate management there by reducing the 
morbidity associated with malignancy. Two important molecular 
factors that is known to be associated with cell proliferation and 
maintaining cell  junction are p63 and β -Catenin respectively.   
AIM:  To evaluate the expression of p63 and β-catenin in different  
grades of oral  squamous cell carcinoma using immunohistochemistry.  
MATERIALS AND METHODS: A total  of 36 samples were examined 
for the immunohistochemical expression of p63 and β-catenin. The 
control group includes 15 formalin fixed par affin embedded tissue 
blocks of normal buccal mucosa. The study group includes 21 cases of 
formalin fixed paraffin embedded tissue blocks of oral squamous cell 
carcinoma (10 cases of well  differentiated and 11 case of moderately 
differentiated squamous cel l carcinoma).  3 micron thickness sections 
were made from each sample and stained with p63 antibody and 
βcatenin antibody. The intensity and area of staining was assessed and 
scored. The data obtained statistically analysed.  
RESULTS: Comparison of staining intensity showed a significant 
difference between normal and well differentiated carcinoma and also 
between normal and moderately differentiated carcinoma. However, no 
significant difference in staining intensity was found between well  
differentiated and moderately differentiated carcinoma. Similarly 
comparison of area of staining showed a significant difference between 
normal and well differentiated carcinoma and also between normal and 
moderately differentiated carcinoma. However, no significant 
difference in area of staining was found between well differentiated 
and moderately differentiated carcinoma.  Comparison of staining 
intensity did not show any significant difference between normal and 
well differentiated carcinoma, between normal and moderately 
differentiated carcinoma and also between well differentiated and 
moderately differentiated carcinoma. Similarly comparison of area of 
staining showed no significant difference between normal and well  
differentiated carcinoma, between normal and moderately 
differentiated carcinoma and also between well differentiated and 
moderately differentiated carcinoma  
CONCLUSION: We conclude that the expression of both β  - catenin 
and p63  can be used as a prognostic marker in oral  squamous cell  
carcinoma.  
KEY WORDS: Squamous cell carcinoma, Immunohistochemistry,                   
β - catenin, p63.  
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INTRODUCTION 
 
Squamous cell carcinoma is the most common malignancy of 
Oral cavity
1 .  It   is defined as a “Malignant epithelial neoplasm 
exhibiting squamous differentiation as characterized by the formation 
of  keratin and the presence of intercellular bridges
2
.   It  is the 8
t h
 most 
common cancer in the world and 3
rd
 most common malignancy in south 
Asia with epidemiologic variation between different geographic 
regions
2 ,
.  The age of individuals diagnosed with oral squamous cell 
carcinoma in developed count ries is more than 60years,  whereas in 
developing countries it  is  between the 4
t h
 to 6
t h
 decades and shows a 
tendency towards  male predominance
3 ,4
.  
 
Oral squamous cell carcinoma (OSCC) results from the multistep 
accumulation of heterogenous genetic changes
4 ,5
.  Important risk factors 
for OSCC include the use of tobacco or betel  quid chewing, alcohol 
consumption, human papilloma virus and poor nutrition
5 -8
.  Most 
frequent sites affected by OSCC are buccal mucosa, tongue and palate
8
.  
The clinical staging is done based on the tumour size,  regional lymph 
node involvement and metastasis (TNM Staging).  Computed 
Tomography (CT) and Magnetic Resonance Imaging (MRI) are used to 
assess the extent of bone and soft  tissue involvement and to ascertain 
the prognosis
9 ,1 0
.  
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Histopathology remains the “Gold Standard” procedure to 
diagnose OSCC till  date  and OSCC is graded histopathologically
1 0
.  
Based on the proportion of the neoplasm resembling normal squamous 
epithelium and the amount of keratin production, lesions are classified  
into three distinct grades as well,  moderate and poorly differentiated 
carcinoma
1
.  The poor prognosis of oral cancer is due to several reasons 
such as late stage of diagnosis, low response to current therapeutic 
strategies, primary site recurrence, high r ate of metastasis to regional 
lymph nodes etc.  This has strongly recommended the need to improve 
the diagnostic capabilities for early detection and managenent
1 1 ,1 2
.  
 
One of the recent advances in the diagnosis of OSCC is 
Immunohistochemistry (IHC).  It  aids in histopathological  analysis by 
detecting gene expression at the protein level
1 3
.  Immunohistochemistry 
is defined as the technique for identifying cellular or tissue 
constituents (antigens) by means of antigen -antibody interaction. The 
site of antibody binding is identified either by direct labelling of 
antibody or by use of secondary labelling method
1 4
.  This is used to 
visualize both normal and diseased states of tissues,  infectious agent 
and other component that  may not be demonstrated by histoch emical or 
special stain
1 5
.   
 
The color of  the reaction is determined by the selection of a 
precipitating chromogen, usually diaminobenzidine (brown) or 
aminoethylcarbazole (red) with which the enzyme reacts. Use of 
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positive and negative controls is of par amount importance and should 
be a routine in immunohistochemistry
1 5
.  Negative controls confirm that  
the staining being reported is due to the antibody binding and posit ive 
controls confirm that the antibody is working and that the suspected 
target of antibody is the acted target
1 4 ,1 5
.  IHC panel using multiple 
prognostic molecular biomarkers can provide information to identify 
high risk patients, thus playing an important role in early diagnosis and 
treatment
1 5 ,1 6
.  
 
Cell cycle is a highly regulated process and involves many 
molecules and interrelated pathways. Mutations of the genes regulating 
the cell proliferation leads to the development of carcinoma. The grade 
of differentiation along with the extent of invasion and metastasis  
largely determines the prognosis of the patient.  For metastasis to 
occur, firstly the cell has to severe its attachment with the adjoining 
cells.  Assessing the tumor behaviour at the molecular level will help 
in initiating appropriate management there by reducing the morbidity 
associated with malignancy.  Two important molecular factors  that  is  
known to be associated with cell  proliferation and maintaining cell  
junction are p63 and β - Catenin respectively1 7 .   
 
p63 is a member of p53 family which is located on chromosome 
3q27-29
1 6
.  It  has been found to play a role in the development of 
epithelial  tissue, epithelial  stem cell maintenance and differentiation 
and thus i t is  vital  for cell cycle regulation
1 8
.  Hence mutation of p63 
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gene will lead to dysregulation  of  cell  proliferation a nd stratification 
thus contributing to carcinogenesis.  In many different tumour types an 
overexpression of mutated p63 has been observed
1 9 ,2 0
.  However its 
expression in OSCC has not been fully explored. Hence we decided to 
select p63 as one of the IHC marker and analyse its expression in 
different grades of OSCC.  
 
β-Catenin is an important component of cell adhesion complex 
and helps in maintaining the structural  integrity and organisation of 
stratified squamous epithelium. It  also acts as an transcription al factor 
in Wnt signalling pathway
2 1 ,2 2
.   The free cytoplasmic accumulation of 
β-Catenin is regulated by APC gene thus inhibit ing transcription of 
factors essential for cell proliferation
2 2 .   Down regulation of β -Catenin 
at the cell junction leads to detachment of the cells from the adjoining 
cells and increased transcription induced by β - Catenin favours cell  
invasion and metastasis. Aberrant expression of β -Catenin have been 
identified in several human cancers
2 3 ,  2 4 .   However the expression of β -
Catenin in OSCC have not been fully explored. Hence we decided to 
perform an IHC study to observe the expression of β - Catenin in 
different grades of OSCC.  
 
With this background we  undertook the current  IHC study to  
analyse  the expression of p63 and  β-Catenin in different grades of  
OSCC.   
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AIM & OBJECTIVES 
 
AIM : 
 To evaluate the expression of p63 and β-catenin in different 
grades of oral  squamous cell carcinoma using Immunohistochemistry.  
 
OBJECTIVES OF THE STUDY: 
1.  To analyse the intensity of p63 expression in normal mucosa, 
well differentiated and moderately differentiated oral  squamous 
cell carcinoma.  
2.  To analyse the intensity of β-catenin expression in normal 
mucosa, well  differentiated and moderately differentiated oral  
squamous cell carcinoma.  
3.  To analyse the area of staining of  p63 in normal mucosa, well  
differentiated and moderately differentiated oral  squamous cell 
carcinoma.  
4.  To analyse the area of staining of β-catenin expression in normal 
mucosa, well  differentiated and moderately differentiated oral  
squamous cell carcinoma.  
5.  To compare the expression of p63 and  β-catenin in well  
differentiated and moderately differentiated oral  squamous cell 
carcinoma.  
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REVIEW OF LITERATURE 
 
β-CATENIN 
 The word catenin is  derived from latin word  “Catena” which 
means Chain. β - Catenin was first discovered in 1980s as a component 
of  E-Cadherin mediated cell adhesion complex. They link the E -
Cadherin to actin cytoskeleton  through α-catenin.  β -Catenin is also a 
key regulatory protein in Wnt mediated signal transduction pathways.  
It  is  encoded by gene CTNNB located in chromosome 3p22
2 4
.  
 
 β-Catenin  is normally found along the cell membrane. APC is a 
tumour suppressor gene which prevents the accumulation of  β - Catenin 
in the cytoplasm by forming macromolecular complex and its  
degradation by ubiquitin –  proteosome pathway2 1 ,2 2 .   Wnt signalling 
blocks APC and allows translocation of  β - Catenin from cytoplasm to 
nucleus.  In the nucleus β - Catenin forms a complex TCF, a 
transcription factor and upregulates cell proliferation
2 4
.  
 
 It   consists of an amino terminal domain with 130 amino acids,  
carboxy terminal domain with 100 amino acids and also contains 42 
amino acids in 12 imperfect  repeats called arm repeats.   Each  arm 
repeat form 3 helixes arranged in the form of triangles. The arm repeat 
(5-9) is the core binding sites of TCF , cadherin and APC and the arm 
repeat (3-4) serves as the binding site for TCF, APC and Axin. The 
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first  arm repeat and the arm repeat 11 C - Terminal is  the region for the 
transactivation of Wnt target genes
1 7
.  
 
 The N and C terminal domains are negatively charged, sensit ive 
to trypsin,  structurally flexible and also act  as „intramolecular 
chaperons‟ of  arm repeat domain. They increase the binding specificity 
of arm repeats and also prevents its  self -aggregation. N terminal 
domain (NTD) is the binding site of α catenin,  GSK3 and CSK -I 
phosphorylation sites which is recognized by β - transducing containing 
proteins ubiquitin ligase (β -TrCP)2 1 .   Helix-C caps the hydrophobic 
surface of the carboxy terminal end of the arm repeat and recruits 
transcriptional coactivators and activates Wnt responsive genes.  
(Figure 1) 
 
 β-Catenin  is essential for maintaining the structural integrity 
and organization of  stratified squamous epithelium
2 4
.  Stabil ization of 
β-Catenin in the cytoplasm leads to increased nuclear transcriptional 
activity.  This is  observed as aberrant expression of β -Catenin  in  many 
malignancies.  
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Figure 1: β- Catenin in Wnt signaling and the cadherin complex  
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β–CATENIN IN ORAL SQUAMOUS CELL CARCINOMA  
 
 Claudia Bagutti et al  (1998)
2 5
 compared the expression of E- 
and P-cadherin with five different integrin subunits and with α, β ,  and 
γ  catenin .They  stained a panel of oral  SCCs with ten different 
antibodies, using double-label immunofluorescence . They found a 
reduced expression of cadherins and integrins in poorly differentiated 
tumours,  while reduced catenin expression was seen in all tumours,  
regardless of differentiation status.  
 
 Gasparoni et al  (2002)
2 6
 analyzed the subcellular localization of 
β-catenin in cultures of human oral normal and malignant (cell lines  
SCC15 and SCC25) keratinocytes. Membranous β -catenin  localization  
appeared in normal cells and decreased progressively in  SCC15 & 
SCC25 Cells. It was mostly cytoplasmic and nuclear in SCC 25 cells.  
In the growth assays, SCC25 cell  lines proliferated faster than in 
normal and SCC15 cells over a period of 6 days.   Carcino ma sections 
showed a combination of membranous and cytoplasmic  staining while 
a  few invading epithelial islands of  tumors sho wed nuclear 
localization of  β -catenin.  
 
 Agnes Bankfalvi et al  (2002)
2 7
 studied about the deranged 
expression of the E-cadherin/ β- catenin complex and the epidermal 
growth factor receptor in the clinical evolution and progression of oral  
squamous cell carcinomas using immunohistochemistry.  All three 
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molecules were constitutionally expressed in the basal/parabasal  layers  
of tumour adjacent „normal‟ epithelium, in contrast to a significant 
increase of EGFR and heterogeneous expression of E-cad/β-cat in 
dysplasia. In OSCCs, overexpression of EGFR correlated significantly 
with lower tumour  grade and poor prognosis, loss of E-cad was a 
significant marker for shortened survival, reduced β -cat staining was a 
predictive  marker for lymph node metastasis.  
 
 N. Tanaka et al  (2003)
2 8
 investigated the immunohistochemical 
expression of E-cadherin,  α-catenin and β -catenin in oral squamous cell  
carcinoma and examined the correlation between their expressions and 
the presence of regional lymph node metastasis. They found a  
significantly greater reduction in expression levels of E -cadherin,  α-
catenin and β -catenin in the metastatic group   compared to the 
nonmetastatic  group. However, there was no significant correlation 
between their expressions and the features of the regional metastasis,  
the number of metastatic lymph nodes or the presence of extracapsular 
metastasis. They concluded that evaluation of the immuno-
histochemical expression of E-cadherin, α-catenin and β -catenin is  
extremely valuable for the diagnosis of metastatic occurrence.  
 
 Stephan  et al  (2004)
2 9
 performed  an   immuno-histochemical 
double staining study to determine the expression and sub-cellular 
distribution of MUC1 and Nuclear β -Catenin in patient with colorectal 
carcinoma. They found that  MUC1 was strongly expressed in tumor 
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center and at the invasive front. Nuclear accumulation of β -catenin was 
found at  the invasive tumor front.  They concluded the nuclear  co -
expression of MUC1 and β -catenin  correlated with poor prognosis.  
 
 Yasusei Kudo et al  (2004)
3 0
 isolated highly invasive clones from 
an OSCC cell line established from a lymph node metastasis by using 
an in vitro invasion assay method and compared the abnormalities of 
cell adhesion molecule E-cadherin and β-catenin in those cells. The 
isolated, highly invasive clones showed significant invasive capacity 
and reduction of E-cadherin and membranous β -catenin protein in 
comparison with parent cells. They found a reduced expression of E -
cadherin which they attributed to methylation of its  promoter region. 
They also found a reduced expression of membranous β -catenin in  
invasive and metastasis areas of OSCC.  The  reduced expression of 
membranous β -catenin was due to its protein degradation. They 
concluded that  E-cadherin methylation and β-catenin degradation can 
be a novel target  for inhibition of invasion and metastasis of OSCC as 
well as a marker for prediction of metastasis.  
 
 Soichi Iwai et al  (2005)
3 1
 studied the Mutations of the APC, β -
catenin and axin 1 using single strand conformation polymorphism 
(SSCP) method and direct sequencing analysis and also studied the 
cytoplasmic accumulation of β -catenin by immunohistochemical 
staining and immunoblot analysis  in the  tissues and cell lines  derived 
from  oral  squamous cell  carcinoma. They found mutation in the APC  
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and Axin 1 gene without amino acid substitution and also cytoplasmic 
accumulation of β-catenin in 75% of cell l ines and 90% of cancer 
tissue samples. They concluded that Axin 1 gene may be a mutational 
target in oral squamous cell  carcinoma and cytoplasmic β -catenin 
accumulation is a characteristic feature but not associated wit h  
mutation of the  APC and β -catenin genes.  
 
 F. Mahomed et al  (2006)
3 2
 studied the expression of E-cadherin 
and β-catenin in oral squamous carcinoma with and without nodal 
metastasis using immunohistochemistry.  They found a significant  
association between E-cadherin / β-catenin and tumor differentiation 
but loss of expression in invasive tumor front in 93% of cases for E -
cadherin and 73% of cases for β -catenin irrespective of the nodal  
status.  They concluded that  there is  an  association between l oss of 
expression of E-cadherin / β-catenin and a lower degree of 
differentiation; and their use as markers of nodal metastasis in oral  
squamous carcinoma appears unreliable.  
 
 Lihong Wand et al  (2007)
3 3
 studied the simultaneous expression 
of desmoglein 3, desmocollin 3 and β -catenin in oral squamous cell  
carcinoma  using immunohistochemistry and tried to correlate it  with 
lymph node metastasis and cell proliferation. They found a    reduced 
or loss of expression of all  markers compared to normal oral  
epithelium. Also found a reduced or loss of expression of Dsc3 in 
advancing histological grade (moderately or poorly differentiated), and 
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reduced or loss of expression of β -catenin in  lymph node metastasis. A 
positive correlation was found  between reduced or loss of  β -catenin 
and Dsc3 staining in lymph node metastatic cancer tissue.  They 
concluded that  abnormal expression of Dsc3, Dsg3, and β -catenin serve 
as a  prognostic marker for  oral squamous cell ca rcinoma.  
 
 CAI Zhi-gang et al  (2008)
2 2
 studied the expression pattern of                
β-catenin in oral  squamous cell  carcinoma using immuno -
histochemistry.  They found a reduced expression of β-catenin in cell  
membrane and increased expression in cytopl asm and nucleus in higher 
grade of malignancy. They concluded that a reduced membranous 
expression of β-catenin is  associated with lymph node metastasis and it  
could be used as a prognostic marker to assess the biological  behivour 
of cancer  progression .  
 
 Soichi Iwai et al  (2010)
3 4
 studied the involvement of Wnt - β-
catenin pathway in invasion and  metastasis of oral squamous cell 
carcinoma cells.   They transfected a mutated ß-catenin cDNA that lacks 
the entire exon-3 including phosphorylation sites specific to glycogen 
synthesis kinase-3ß into Ca9-22 cells. They found an increased 
expression of transcription factor T -cell factor (Tcf) / lymphoid 
enhancer factor (Lef)-dependent reporter gene activity as well as  up -
regulation of Wnt /  ß-catenin target  gene matrix metalloproteinase 
(MMP)-7 in these mutated cells. They also found redistribution of           
E-cadherin,  rearrangement of actin filaments, and the elevation of 
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active Rho family members,  Cdc42 and Rac. They concluded that  β-
catenin has an important role in invasion and metastasis of oral 
squamous cell carcinoma.  
 
 Lai-Kui Liu et al  (2010)
3 5
 studied the immunohistochemical 
expression of  vimentin,  E- cadherin and β -catenin complex  in oral 
squamous cell carcinoma. They found an increased expression of 
vimentin and decresed expression of E -cadherin in recurrent tumors.   
Decresed β-catenin expression was seen in invasive tumor front . They 
concluded that vimentin,  E- cadherin and β -catenin may serve as a 
useful prognostic marker in oral  squam ous cell  carcinoma.  
 
 S.Y. Chaw et al  (2012)
5
  studied the role of  E-cadherin,  β-
catenin,  APC and vimentin as  epithelial to mesenchymal transition 
biomarkers  in oral  squamous cell  carcinoma using  using a novel 
organotypic cell invasion model based on human dermis.  They found a 
decreased E- cadherin expression and an increased vimentin and APC 
expression with increased disease severity.  A shift in β -catenin 
expression  from membranous to cytoplasmic / nuclear  staining was 
noticed with increase  in  his topathological grade of severity. They 
concluded that aberrant expression of β -catenin, APC and Vimentin are 
potential markers of malignant transformation.  
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 Khaled Waleed Zaid et al  (2014)
9
 performed an 
immunohistochemical assessment of E -cadherin and β-catenin in 
different histological grades of Oral Squamous Cell Carcinoma. They 
found a significant decrease in E-cadherin expression as the grade 
advanced. A significant correlation was found between β -catenin 
expression and histological grades.  Express ion of β-catenin shifted 
from membrane to cytoplasm and nuclear as a histological  grades 
advanced. They also found a significant correlation between E -cadherin 
and β-catenin expression. Thus the can be used as prognostic marker in  
oral squamous cell carcinoma.  
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p63 
 P53 is a tumor suppressor gene first described in 1979. Two 
homologue of p53 namely p63 and p73, which has structural similarity 
to p53 were discovered in 1997
1 9
.   The p53 family consist  of 3 main 
domains which are N-terminal transactivation  domain (TAD), D NA 
binding domain (DBD) and the oligomerization domain (OD). Human 
p63 gene contains 14 exons spreading more than 250kb on chromosome 
3q27
1 9 ,2 0
.   
 
 Alternative splicing at 3‟ end of RNA leads to the formation of 
three p63 isoforms namely α, β and γ which differ s in C- Terminal 
length.  Based on the presence of  transactivating (TA) domain  in the 
N- Terminal  two different isoforms are produced. Those with the TA 
domain are the TAp63 isoforms and those which lack the TA domain 
are the truncated isoforms ∆Np63. Thus in total six different isoforms 
of p63 are present which are TAp63α, TAp63β, TAp63γ, ΔNp63α, 
ΔNp63β, ΔNp63γ1 9 ,2 0 .  (Figure 2) 
 
 The TAp63 isoforms  transactivates  by binding to p53 
responsive reporter genes, thus functions similar to p53. On the other 
hand the ∆Np63 isoforms which lacks TA domain competitively binds 
to p53 consensus si tes through DNA binding domain, thus acting as  
dominant negative inhibitor of p53 and p63 transactivation
1 9 ,2 0
.   
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 P63 plays an important role in the maintenance of surface 
epithelium. It  maintains the stem cell  population and also plays an 
important role in  differentiation of  squamous epithelium. Thus  any 
alteration in p63 expression could be a contributing factor  to 
neoplastic cell transformation.  
 
Figure 2: The human p63  spl icing isoform. (A) Schematic 
representation of intron/exon structure of the human p63 gene.  (B) 
Schematic representation of the human p63 protein splicing variants.  
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p63 
 Karin Nylander et al  (2000)  
3 6  
studied the expression pattern of 
p63α and ∆Np63α in benign and malignant oral  epithelial  lesion using 
immunohistochemistry.  They found that  p63 isoforms were expressed 
in the nucleus of many cells.  In normal and benign lesions,  
p63α/∆Np63α-expressing cells were mainly found suprabasally,  
whereas p53-expressing cells were restricted to the basal -cell layer.  
With RT-PCR, they found ∆Np63α is the predominant isoform in cell  
lines from squamous-cell carcinomas of the head and neck.  They 
concluded that  p63 isoforms has a distinct role in growth and 
differentiation of epithelial  cells and is highly amplified in different 
grades of squamous cell carcinoma.  
 
  Hai Hu et al  (2002)
3 7
 investigated the expression of p63 protein 
in human esophageal squamous cell  carcinomas using 
immunohistochemistry and reverse transcriptase polymerase chain 
reaction. They found that  the ∆Np63 mRNA was easily detectable in all  
malignant and histologicall y normal t issues, whereas TAp63 presented 
extremely low or no expression. The expression was found in the basal  
and Suprabasal layer. They concluded that increased p63 expression 
could be an early marker in esophageal squamous cell carcinomas.  
 
 Hong-Ran et al  (2002)
3 8
 studied the differential expression of 
p53 gene family members p63 and p73 in HNSCC by 
immunohistochemical analysis and compared i t with clinicopathologic 
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parameters in 38 patients. They found that in histologically normal 
epithelium p53 and p73 showed basal and/or parabasal expression. p53 
expression was weak  and discontinuous while a stronger expression of  
p63 in suprabasal cells  was found.  In dysplasias, all  three markers 
showed a gradual increase in the extent and intensity of cellular  
expression with histologic progression. In carcinomas, p63 was highly 
expressed followed by p73 and p53. Significant correlation was found 
between   p63 and p73 expression. Distant metastasis and 
perineural/vascular invasion showed p73 expression. They concluded 
that  p63 and p73 expression is associated with head and neck cancer 
development and progression.   
 
 Karin Nylander et al  (2002)
3 9
 studied the differential  
expression of p63 isoforms in normal tissues and neoplastic cells by 
producing three antibodies produced  against  the two N-terminal 
isoforms (TAp63 and Np63) and the C -terminal region of the p63α 
proteins.  TAp63 proteins were located suprabasally in stratified 
epithelia compared with the N-terminal truncated forms, which were 
more abundantly expressed in the basal cell  layer, indicating a  switch 
in expression of p63 iso forms during normal cellular differentiation.  
In squamous cell carcinomas Np63α was the widely expressed  isoform, 
thus a  role in promoting  neoplastic cell growth. TAp63, but  not Np63 
or p63α ,  was detected in normal colon and in colon carcinoma. TAp63 
proteins were also expressed in the nuclei  of a sub -population of 
lymphoid cells and in most malignant lymphomas, whereas Np63 
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proteins were not expressed. They concluded that di fferent p63 
proteins are expressed during differentiation and  progression of 
neoplasia.  
 
 Keith E. Matheny et al  (2003)
4 0  
studied the molecular  
relationship between epidermal Growth Factor Receptor (EGFR) and 
p63 expression using  ZD1839, an  adenosine t riphosphate competitive 
inhibitor specific to the EGFR tyrosine kinase, in human head and neck 
squamous cell carcinoma cell  line,  SCC-012 using flow cytometry.  p63 
protein and mRNA  levels were analyzed by Western and Northern blot  
analyses.  They found a dose-dependent decrease in p63 protein and 
mRNA levels over the course of ZD1839 treatment. Levels of  
phosphorylated MAPK decreased and p27KIP -1 levels increased after 
ZD1839 treatment.  ZD1839 treatment induced a twofold increase in 
G1-phase cells and a 3 .5- fold decrease in S-phase cells consistent with 
growth arrest.  They conclude that  p63 is a downstream target of EGFR 
signaling.  
 
 Paul C. Edwards et al  (2004)
4 1
 studied the 
immunohistochemical expression of p63 in  benign (basal  cell and 
canalicular adenomas) and malignant (adenoid cystic carcinoma (ACC), 
polymorphous low-grade adenocarcinoma (PLGA) ) salivary gland 
neoplasms. PLGA showed 100% positivity and ACC showed 87% of 
positivity primarily in the nonluminal myoepithelial -like cells.  
Canalicular adenoma showed no immunoreactivity.  All  basal cell  
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adenomas of parotid origin stained strongly for p63 but those from 
upper lip showed no staining. They concluded that p63 is not an ideal 
marker to distinguish between ACC, PLGA, and basal cell adenoma.  
 
 Maria P. Foschini et al  (2004)
4 2
 performed an 
immunohistochemical study to  define the role of p63 in oral  squamous 
cell carcinomas using  a monoclonal antibody recognising all p63 
isoforms and an anti -Ki67 antibody.  p63 mRNA expression pattern 
was evaluated using  reverse-transcription polymerase chain reaction 
(PCR) and nested PCR. They found that  p63 was positive in all OSCC 
similar to ki67. The percentage of p63 positive cells increased from 
normal to neoplastic mucosa. However there was no relationship 
between the number of p63 positive cells and prognosis. In metastases 
the truncated isoforms D4TAp63 and DNp73L were more frequently 
expressed. They concluded that  impaired p63 isoform expression have 
a role in cell proliferation and indirectly enhance the m etastasising 
capacity of OSCC.  
 
 Marcelo C. Bortoluzzi et al  (2004)
4 3
 assessed the p63 
expression in oral squamous cell carcinomas and dysplasias using 
immunohistochemistry.  They also assessed p53 and ki67 in this lesions.  
They found that p63 stained suprabasally in the entire non invasive 
lesion, most nuclei  in invasive lesion stained positive for p63, 
moderately differentiated SCC stained more than that  of well  
differentiated SCC. They concluded that though p63 staining was 
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evident in all lesions it could  not be used to differentiate the lesion. 
p63 is not coexpressed with p53 expression or Ki -67 suggesting 
functional independence.  
 
 Joseph C. Sniezek et al  (2004)
4 4
 studied the differential  
expression of p63 isoforms  in head and neck squamous cell  carcin oma 
and oral l ichen planus  using immunohistochemistry.  Western blot 
analysis was done to confirm the p63 isoforms. To analyse and 
quantitatively compare p63 isoform expression at the RNA level RT -
PCR was performed. They found p63 expression in all tumors and 
normal tissue specimens and found ∆Np63α to be the major isoform 
expressed. They also found underexpression of p63 in oral lichen 
planus. They concluded that ∆Np63α plays antidifferentiation and anti -
apoptotic role in HNSCC.  
 
 Niklas Thurfjell et al  (2004)
4 5
 performed real t ime RT-PCR to 
study p63 isoform HNSCC. They found ∆Np63α to be the major 
isoforms and that it  is highly expressed in tumors compared to normal 
tissue. They found that  p63β was also highly expressed in tumors.  
However correlations between different p63-isoform expression 
patterns and proliferation, p53 status,  or telomerase expression could 
not be found. The high expression of ∆Np63 found in basal  layers of  
normal epithelium were similar to those found in tumors.  They 
suggested that  high-level expression of ∆Np63 in tumour cells 
represents the maintained expression by the basal cells from which the 
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tumour originated, rather than representing a true over -expression of 
p63 during tumourigenesis.  They also showed that tobacco usage had  
no effect on p63 expression in oral epithelium.  
 
 James W. Rocco et al  (2006)
4 6
 demonstrated the role of  ∆Np63α 
as an essential  survival factor in HNSCC. They studied the p63 isoform 
expression in human HNSCC derived cell lines JHU -029 expressing 
TAp63 and JHU-011 expressing truncated mutant p63. They found that  
p63 expression is three to five times higher than normal in HK cell  
lines. Through QRT-PCR ∆Np63 mRNA was found to be the 
predominant isoform. They demonstrated the functional role of 
endogenous p63 in HNSCC cells by RNA mediated interferences using 
p63 targeted small  hairpin RNA(shRNA) and found that specific 
inhibit ion of p63 in  significant fraction of cells undergoing apoptosis.  
With this they showed that p63 promotes survival of squamous cell  
carcinoma cells by suppressing the proapoptotic function of p73.  
 
 Lorenzo Lo Muzio et al  (2005)
4 7
 investigated the role p63 in 
oral cancer and its potential as prognostic marker using 
immunohistochemistry.  p63 expression was seen in basal and parabasal 
layer in normal tissues, carcinoma in situ and well differentiated 
neoplasm. Diffuse staining was seen in grade II neoplasm. Completely 
dedifferentiated neoplasm showed negative or faint staining. Intense 
and diffuse labelling was seen in infiltrat ing neoplasm.  No staining 
was observed in keratin pearl areas.  They found no significant 
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correlation between p63 expression, sex, age, tumor size, staging, 
recurrence and metastasis. They concluded that p63 expression can be 
useful to identify aggressive and invasive OSCC and can be used as a 
prognostic marker.  
 
 Lucinei Roberto de Oliveira et al  (2006)
4 8
 investigated the 
impact of  p53 and p63 immunoexpression in oral squamous cell 
carcinoma. P63 expression was found in the well and moderately 
differentiated tumors and absent in terminally differentiated cells and 
keratin pearl areas. P53 was found in 52% of tum ors. No significant 
correlation was found between p63 expression and both tumour 
recurrence and metastasis. p53 positive cases showed higher metastatic 
rate. They conclude that  p53 over -expression and decreased intensity 
of p63 staining is associated with metastasis.  
 
 Anju Sinha et al  (2015)
4 9
 studied the expression of p63 in 
potentially malignant and malignant lesions using 
immunohistochemistry.  Increased expression and mean labeling index 
of p63 was seen in oral  sub mucous fibrosis (57%), epithelial  dys plasia 
(63%) and carcinoma (70%).  They suggested that increased labelling 
index and supra basal expression of p63 in dysplasia can be used as a 
marker for pre-malignancy.  
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 Nasrollah Saghravanian et al  (2017)
5 0
 studied the correlation of  
p63 and CD44 expression with clinicopathological parameters like 
histological grading, TNM staging, overall survival rate,   patient age, 
gender and tumor location. No significant relation found between the 
markers and patients age, gender,  tumor location and overall  su rvival 
rate.  Increased CD44 and p63 expression was seen in higher grades of 
carcinoma. They suggested that these markers can be further studied to 
understand the pathogenesis of OSCC and a potential target in cancer 
treatment.  
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MATERIALS AND METHODS  
 
STUDY DESIGN AND CASE SELECTION:  
 This immunohistochemical study, to analyse the immunohistochemical 
expression of p63 and β-catenin was done on the archival retrieved 
formalin fixed, paraffin embedded tissues obtained from the 
Department of Oral  Pathology, Adhiparasakthi Dental College and 
Hospital, Melmaruvathur.  
 
The study group includes histologically diagnosed  
  Well differentiated squamous cell  carcinoma- 10 
  Moderately differentiated squamous cell carcinoma - 11 
  Normal tissue for control - 15  
  Total  no  of samples - 36 
  Control group includes biopsies from the normal buccal mucosa 
or gingiva adjacent to the site of surgery during the surgical  
removal of third molar in 15 patients.  
 
 For posit ive control ,  archival retrieved formalin fixed, paraffin 
embedded colon cancer for β -catenin staining and normal prostate for 
p63 staining was obtained f rom the Department of General  Pathology,  
Melmaruvathur Adhiparasakthi Institute of Medical Science and 
Research, Melmaruvathur.  
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ARMAMENTARIUM
1 4 ,1 5 ,2 2
  (Figure-3) 
  Microtome  (Thermo scientific, MICROM HM340E)  
  Paint brush 
  Disposable microtome blades  
  Hot plate  
  Hot water bath  
  PathnSitu positively charged slides  
   Pressure cooker (5 Liters)  
   Measuring Jars  
   Coplin Jars  
   Electronic Timer  
   Absorbent wipes  
   Coverslip for slides  
  Binocular Light Microscope (Olympus CX21i)  
  Micropipette  
  Rectangular steel trough 
  Induction stove 
  Incubator  (Hitech Equipments)  
  Liquid repellent slide marking pen  
  Deparaffinization stainless steel staining trough and rack  
  pH meter (E1 digital  pH meter)  
  A DELTA PLAN2 AP40 Trinocular Light Microscope with 
camera Head  
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  ANTIBODIES: 
1.Primary antibody   
a)  Anti-p63 [Mouse monoclonal antibody] –  4A4 (PathnSitu 
Biotechnologies Private Limited)  
b)  Anti-βcatenin [Rabbit monoclonal antibody] - EP35 (PathnSitu 
Biotechnologies Private Limited)  
 
2. Secondary kit  (PolyExcel  HRP/DAB Detection System) - PathnSitu  
Biotechnologies Private Limited  
a)  PolyExcel H2O2  
b)  PolyExcel Target Binder  
c)  PolyExcel Poly HRP 
d)  PolyExcel stun DAB –  Chromogen  
e)  PolyExcel stun DAB –  Buffer  
 
  REAGENTS1 4 ,1 5 ,2 2:  
  Tris-EDTA Buffer –  50X concentration (PathnSitu 
Biotechnologies Private Limited)  
   Immuno wash Buffer –  25X concentration (PathnSitu 
Biotechnologies Private Limited)  
   Distilled water  
   Xylene 
  Absolute alcohol (Isopropyl Alcohol)  
  Alcohol 90% (Isopropyl Alcohol)  
   Alcohol 70% (Isopropyl Alcohol)  
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   Harris Hematoxylin  
   Mountant (Dibutyl  Phthalate Xylene)  
 
IHC METHODOLOGY
1 4 ,1 5
: 
 Formalin fixed paraffin embedded tissues were sectioned at  3µm 
and mounted on charged slides and kept for overnight incubation 
at 37
o
C 
 Prior to staining slides were incubated at  60 –  70 oC for 1 hour  
 Deparaffinized by 2 changes of xylene 10 minutes each  
 Hydrated through descending grades of alcohols as follows:  
  Absolute alcohol –  1 change, 5 minutes  
  90% alcohol –  5 minutes  
  70% alcohol –  5 minutes 
 Distilled water wash  2 changes each for 2 minutes  
 Antigen retrieval done for 15 - 20 minutes (upto 2 whistles in 
pressure cooker)  
 Cooled for minimum of 30 minutes  
 Distilled water wash  2 changes each for 2 minutes  
 Washed in PBS / TBS  for 2 minu tes 
 Circles were marked enclosing the section using liquid repellent 
pen  
 Endogenous peroxidase blocking was done by adding PolyExcel 
H2O2  on the section, keep for 5 minutes  
 Washed in wash buffer for 5 minutes, 3 changes  
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 Primary antibody was added and kept  for 30 minutes for p63 and 
45 minutes for β  catenin  in a moist  chamber  
 Washed in wash buffer for 5 minutes, 3 changes  
  PolyExcel Target Binder reagent was added and incubated for 12 
minutes  
 Washed in wash buffer for 5 minutes, 3 changes  
 Polyexcel HRP was added and incubated for 12 minutes  
  DAB solution was prepared (1 ml of DAB buffer + 1 drop DAB 
chromogen) 
  Washed in wash buffer for 5 minutes,  3 changes  
 Working DAB chromogen was added and kept for 2 -5 minutes,  
then washed in distil led water.  
 Counterstained with hematoxylin for 30 seconds  
 Washed in running tap water for 5 minutes  
 Dehydrated through successive changes of alcohol and clear with 
xylene 
 Dried and mounted with DPX 
 
POSITIVE CONTROLS 
1.  Positive control  section for p63 includes normal prostate and was 
treated in the same manner as the test  groups.  
2.  Positive control  section for βcatenin includes colon cancer and was 
treated in the same manner as the test  groups.  
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NEGATIVE CONTROLS  
 One section of test sample was selected and treated in the same 
manner as the test  groups except that, the primary antibody was 
omitted for both p63 and βcatenin.  
 
ANALYSIS OF IMMUNOREACTIVITY OF p63 AND β-CATENIN :  
 To know the expression pattern and also to determine the levels 
of protein expression in the epithelial  layers,  area of staining was 
analysed. It  was determined by scanning the entire section of the 
epithelium on the surface and also the invaded cells and islands in the 
case of carcinoma and was recorded as  
SCORE INFERENCES 
0 0% 
1 <25% 
2 25 - 49% 
3 50 - 74% 
4 75 - 100% 
  
 To know the extent of stain uptake, intensity of staining was 
analysed. Ten random fields were selected at 40x magnifications and 
were scored as:   
 
SCORE INFERENCES 
0 No stain 
1 Mild staining 
2 Moderate staining  
3 Intense staining 
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Figure 3 : ARMAMENTARIUM 
  
 
 
 
 
 
 
 
 
 
Fig 3 (a) Microtome Fig 3 (b) Induction stove and 
Pressure cooker 
Fig 3 (c) Electronic Timer Fig 3 (d) Microscope 
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Fig 3 (f) Incubator Fig 3 (e) Micropipette 
Fig 3 (g) Reagent blocker 
Fig 3 (h)  Deparaffinization stainless steel staining trough and rack 
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Fig 3 (i) Primary antibody Anti -
p63[Mouse Monoclonal antibody] 
Fig 3 (j) Primary antibody 
Anti– βcatenin [Rabbit 
Monoclonal antibody] 
Figure  3 (k) Secondary kit 
 
Figure 3(l) DAB Chromogen and 
DAB buffer[H2O2, Target 
Binder, Poly HRP] 
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Fig 3 (o)   Hematoxyline 
 
Fig 3 (m) Tris – 
EDTA 
Fig 3 (n)  Wash Buffer 
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RESULTS 
 
 The present study was undertaken to analyse the 
immunohistochemical expression of p63 and β -catenin in different 
grades of oral  squamous cell  carcinoma. Previously diagnosed 10 cases 
of  well  differentiated squamous cell carcinoma, 11 cases of 
moderately differentiated squamous cell carcinoma and 15 normal 
tissues  as control were selected  from the departmental archives.  
 
 Serial  sections of 3μ thickness were made and stained separately 
for p63 and β-catenin using immunohistochemistry.  Intensit y of 
staining was assessed by selecting 10 random fields under high power 
magnification and scored as 0- no stain, 1-mild, 2-moderate, 3-Intense.  
The area  of staining was determined by scanning the  entire section for  
epithelial  uptake of stain  and  sco red as 0(0%), 1(<25%), 2(25-49%),  
3(50 - 74%), 4(75 - 100%).  
 
 Scoring was done for p63 (n=36) and β -catenin (n=36) [Annexure 
2]. The staining intensity scores for β -catenin ranged between 1 & 3, 0 
& 3 for well differentiated and moderately differentiated  carcinoma 
respectively.  The normal t issues uniformly scored 3.  
 
 The staining intensity scores for p63 ranged between 2 & 3, 1 & 
3 for normal and moderately differentiated carcinoma respectively.  The 
well differentiated carcinoma uniformly scored 3.  
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 The scores for β -catenin area of staining ranged between 3 & 4, 
1&4,0 &4 for normal, well differentiated and moderately differentiated 
carcinoma respectively.   
 
 The scores for p63 area of staining ranged between 2 &  4 for 
both normal and well  differentiated carcinoma. The score ranged 
between 1 &4 for moderately differentiated carcinoma.  
 
The data obtained was statistically analysed.  
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β-CATENIN 
Table 1: Comparison of β-catenin intensity and area of staining 
between the groups  
β-catenin N Mean 
Std. 
Deviation 
Minimum Maximum P-value 
Staining 
intensity 
Normal 15 3.00 0.000 3 3 
0.001* 
Well Differentiated 
Carcinoma 
10 2.10 0.876 1 3 
Moderately 
Differentiated 
carcinoma 
11 1.82 1.168 0 3 
Area 
Normal 15 3.80 0.414 3 4 
0.002* 
Well Differentiated 
carcinoma 
10 2.60 1.075 1 4 
Moderately 
Differentiated 
carcinoma 
11 2.45 1.293 0 4 
* denotes statistically significant using Kruskall Wallis’ ANOVA  
Intensity of Staining  
 The mean score for intensity of staining of normal t issue, well  
differentiated carcinoma and moderately differentiated carcinoma was 
found to be 3.0 (SD 0), 2.1 (SD 0.87) & 1.82 (SD 1.16) respectively.  
The difference between the mean scores was found to be statistically 
significant (p < 0.05) using Kruskall Wallis ANOVA (Table 1).  
 
Area of staining  
 The mean score for area of staining of normal tissue, well  
differentiated carcinoma and moderately differentiated carcinoma was 
found to be 3.80 (SD 0.4), 2.60 (SD 1.0) & 2.45 (SD 1.2) respectively.  
The difference between the mean scores was found to be statistically 
significant (p < 0.05) using Kruskall Wallis ANOVA (Table 1).  
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Table 2: Inter group comparison of β -catenin staining  intensity 
using Mann Whitney U test  
Groups N Mean Std. 
Deviation 
Minimum Maximum P-value 
Normal 15 3.00 0.000 3 3 0.012* 
Well Differentiated carcinoma 10 2.10 0.876 1 3 
Normal 15 3.00 0.000 3 3 0.005* 
Moderately Differentiated carcinoma 11 1.82 1.168 0 3 
Well Differentiated carcinoma 10 2.10 0.876 1 3 0.654 
Moderately Differentiated carcinoma 11 1.82 1.168 0 3 
* denotes statistically significant  
 We compared the staining intensity mean score between the 
normal and well differentiated carcinoma using Mann whitney U test 
and found  the difference to be statistically significant (Table 2).  That 
is there is decrease in intensity of β -catenin expression in well  
differentiated carcinoma compared to the normal tissues.  
 
 We compared the staining intensity mean score between the 
normal and moderately differentiated carcinoma  using Mann whitney 
U test  and found  the difference to be statistically significant (Table 2).  
That is  there is decrease in intensity of β -catenin expression in  
moderately differentiated carcinoma compared to the norma l tissues.  
 
 We compared the staining intensity mean score between well  
differentiated and moderately using Mann whitney U test . However we 
did not find any significant difference between the mean scores ( Table 
2).  That is  there is  not much d ifference in the intensity of β -catenin 
expression in well  differentiated and moderately differentiated 
carcinoma.  
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Table 3: Inter  group comparison of Area of β -catenin staining 
using Mann Whitney U test  
Groups N Mean Std. 
Deviation 
Minimum Maximum P-value 
Normal 15 3.80 0.414 3 4 0.004* 
Well Differentiated carcinoma 10 2.60 1.075 1 4 
Normal 15 3.80 0.414 3 4 0.005* 
Moderately Differentiated 
carcinoma 
11 2.45 1.293 0 4 
Well Differentiated carcinoma 10 2.60 1.075 1 4 0.863 
Moderately Differentiated 
carcinoma 
11 2.45 1.293 0 4 
* denotes statistically significant  
 We compared the mean scores of area of staining between the 
normal and well differentiated  carcinoma  using Mann whitney U test  
and found  the difference to be statistically significant (Table 3).  That 
is, there is decrease in area of β -catenin expression in well  
differentiated carcinoma compared to the normal tissues.  
 
 We compared the mean scores of area of staining between the 
normal and moderately differentiated carcinoma  using Mann whitney 
U test  and found  the difference to  be statistically significant (Table 3).  
That is , there is  decrease in area of β -catenin expression in moderately 
differentiated carcinoma compared to the normal tissues.  
 
 Next we compared the mean scores of  area of staining  between  
the well  differentiated and moderately  differentiated  carcinoma  using 
Mann whitney U test  and found  that  there is no significant  differ ence  
in the  scores obtained (Table 3). That is area of staining cannot be 
used to differentiate between well differentiated and moderately 
differentiated carcinoma.  
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p63  
Table 4 : Comparison of p63 intensity and area of staining between 
the groups using Kruskall Wallis ANOVA  
p63 N Mean 
Std. 
Deviation 
Minimum Maximum 
P-
value 
Staining 
intensity 
Normal 15 2.60 0.507 2 3 
0.091 
Well Differentiated 
carcinoma 
10 3.00 0.000 3 3 
Moderately 
Differentiated carcinoma 
11 2.64 0.674 1 3 
Area 
Normal 15 3.20 0.775 2 4 
0.439 
Well Differentiated 
carcinoma 
10 2.80 0.632 2 4 
Moderately 
Differentiated carcinoma 
11 2.91 1.044 1 4 
 
Intensity of Staining  
 The mean score for intensity of staining of normal t issue, well  
differentiated carcinoma and moderately differentiated carcinoma was 
found to be 2.6 (SD 0.5),  3.0 (SD 0.0) & 2.64 (SD 0.6) respectively.  
The difference between the mean scores was not found to be 
statistically significant using Kruskall Wallis ANOVA (Table 4).  
 
Area of staining  
 The mean score for area of staining of normal tissue, well  
differentiated carcinoma and moderately differentiated carcinoma was 
found to be 3.20 (SD 0.7), 2.80 (SD 1.6) & 2.91 (SD 1.0) respectively.  
The difference between the mean scores was found to be statistically 
not significant using Kruskall  Wallis ANOVA (Table 4).  
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Table 5: Inter  group comparison of p63 staining  intensity using 
Mann Whitney U test  
Groups N Mean Std. 
Deviation 
Minimum Maximum P-value 
Normal 15 2.60 0.507 2 3 0.103 
Well Differentiated carcinoma 10 3.00 0.000 3 3 
Normal 15 2.60 0.507 2 3 0.721 
Moderately Differentiated 
carcinoma 
11 2.64 0.674 1 3 
Well Differentiated carcinoma 10 3.00 0.000 3 3 0.314 
Moderately Differentiated 
carcinoma 
11 2.64 0.674 1 3 
* denotes statistically significant  
 We compared the p63 staining intensity mean score between the 
normal and well differentiated  carcinoma  using Mann whitney U test  
and found no significant  difference. This shows that the staining 
intensity cannot be used to differentiate between normal and well  
differentiated carcinoma.  
 
 We compared the p63 staining intensity mean score between the 
normal and moderately differentiated  carcinoma  using Mann whitney 
U test and found no significant difference. This shows that the staining 
intensity cannot be used to differentiate between normal and 
moderately  differentiated carcinoma.  
 
 We compared the p63 staining intensity mean score between the 
well differentiated and moderately differentiated carcinoma using 
Mann whitney U test and found no significant  difference. This shows 
that  the staining intensity cannot be used to differentiate between 
normal and moderately differentiated carcinoma.  
 
 Hence p63 staining intensity does not contribute to differentiate 
between normal and different grades of carcinoma.  
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Table 6: Inter  group comparison of Area  of  p63 staining using 
Mann Whitney U test  
Groups N Mean Std. 
Deviation 
Minimum Maximum P-value 
Normal 15 3.20 0.775 2 4 0.216 
Well Differentiated 
carcinoma 
10 2.80 0.632 2 4 
Normal 15 3.20 0.775 2 4 0.54 
Moderately Differentiated 
carcinoma 
11 2.91 1.044 1 4 
Well Differentiated 
carcinoma 
10 2.80 0.632 2 4 0.705 
Moderately Differentiated 
carcinoma 
11 2.91 1.044 1 4 
* denotes statistically significant  
 
 We compared the mean scores of p63 area of staining between  
the normal and well  differentiated  carcinoma  using Mann whitney U 
test and found  no significant difference (Table 6). This shows that 
area of p63 expression cannot be used to differentiate between the 
normal tissues and well differentiated carcinoma.  
 
 We compared the mean  scores of p63 area of staining between 
the normal and moderately  differentiated  carcinoma  using Mann 
whitney U test and found  no significant difference (Table 6).  This 
shows that  area of p63 expression cannot be used to differentiate 
between the normal t issues and moderately differentiated carcinoma.  
 
 We compared the mean scores of p63 area of staining  between  
the well differentiated  and  moderately  differentiated  carcinoma  
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using Mann whitney U test and found  no significant difference (Table 
6).  This shows that area of p63 expression cannot be used to 
differentiate between the well differentiated and moderately 
differentiated carcinoma.  
 
 Hence p63 area of staining does not play a significant role to 
differentiate between normal tissue and different grades of carcinoma.  
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Figure 4 :  Photomicrograph of IHC stained section showing strong 
positive cell membrane  expression of  β-catenin  in colon cancer 
(positive control) at  low power  magnification(a) and at  high power 
magnification(b).  
 
a) 
 
b) 
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Figure 5 (a) : Photomicrograph showing H&E stained section in 
normal tissue at  low power magnification . (b & C):  Photomicrograph 
of IHC stained section showing membranous expression of β -catenin in 
normal tissue at   low power magnification (b) & at  high power  
magnification (c).     
 
 
  
          a)          b) 
 
 
c) 
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Figure 6 (a): Photomicrograph showing H&E stained section in  well  
differentiated SCC at  low power magnification.  (b &c): 
Photomicrograph of IHC stained section showing membranous 
expression of  β-Catenin in  well differentiated carcinoma at  low power 
magnification (b) and  at high power magnification (c).  
 
   
          a)          b) 
 
 
c) 
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Figure 7(a) :  Photomicrograph showing H&E stained section  of 
moderately  differentiated carcinoma  at   low power magnification.  
(b&c):  Photomicrograph of IHC stained section showing  membranous 
and cytoplasmic expression of  β catenin in  moderately  differentiated 
SCC at  low power magnification (b) and high power magnification (c).  
 
  
          a)          b) 
 
 
c) 
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Figure 8(a&b): Photomicrograph showing IHC stained section of 
moderately differentiated  carcinoma showing no uptake of stain in 
invaded islands at   low power magnification (a) and high power 
magnification(b)  
 
a) 
 
b) 
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Figure 9(a&b):  Photomicrograph of IHC stained section showing 
strong positive nuclear expression of p63 in normal prostate (positive 
control) at low power magnification (a) and high power magnification 
(b) 
  
a) 
 
b) 
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Figure 10(a): Photomicrograph showing H&E stained section  showing 
normal tissue at  low power magnification.  (b&c):  Photomicrograph of 
IHC stained section showing  strong nuclear expression of p63  in 
normal tissue at   low power  magnification (b) and high power 
magnification (c) .  
 
  
          a)          b) 
  
c) 
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Figure:11(a) Photomicrograph showing H&E stained section well  
differentiated carcinoma at low power magnification.  (b&c):  
Photomicrograph  of  IHC stained section showing  strong nuclear 
expression of p63 in  well differentiated carcinoma  at  low power 
magnification(b) and high power magnification (c).T he lack of staining 
in the keratin pearls can be appreciated .  
 
  
          a)          b) 
 
 
c) 
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Figure 12(a):  Photomicrograph showing H&E stained section  showing 
moderately differentiated carcinoma at   low power magnification . 
(b&c): Photomicrograph  of IHC stained section  showing  strong  
nuclear expression of p63 in  moderately differentiated  carcinoma at   
low power magnification (b) & high power magnification (c)  
 
  
          a)          b) 
 
 
c) 
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DISCUSSION  
 
Carcinogenesis is a multistep process in which there is a clonal 
selection and expansion of genetically altered cells
1
.  As changes at the 
molecular level occurs even before any cellular or clinical changes a 
precise and reliable system to detect these changes will  help in early 
identification of high risk patients and initiate early management 
thereby reducing the morbidity associated with the lesion
5 1
.   
 
Squamous cell  carcinoma is the most common malignancy 
affecting the oral  cavity
1 ,7
.  Most of the cases present with advanced 
lesions at the time of diagnosis.  Histological grade of differentiation & 
invasion and metastasis & staging determines the prognosis of the 
patient.  
 
Cell adhesion molecules play an essential role in maintaining the 
structural  integrity of epithelial cells  by regulating their growth and 
differentiation
5 2
.  Reduction in the intercellular adhesion is often 
associated with loss of epithelial cell differentiation and increases their 
potential to invade and metastasize. E -Cadherin in association with 
cytolpasmic regulatory proteins α,  β,  γ catenin essentially forms  the 
cell junction (Figure 1)
5 3 .  β-catenin also acts as a transcription co -
factor in Wnt signaling pathway and forms complex with transcription 
factor LEF1 in the nucleus
5 4
.   
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Thus analysing the expression of β -catenin in oral squamous cell  
carcinoma has a potential to predict the biological behavior of the 
lesion. Hence we decided to determine objectivel y the molecular 
expression of β -catenin in oral squamous cell  carcinoma   using 
immunohistochemistry.  
 
In our study previously diagnosed 10 cases of well  differentiated 
carcinoma and 11 cases of moderately differentiated carcinoma were 
selected. 15 normal tissue samples were selected as controls. Colon 
cancer was selected as posit ive control.  
  
Immunohistochemical expression of β -catenin was analyzed 
based on the intensity of stain uptake and area of epithelial  staining. 
Intensity of staining was scored as nil  (0),  mild (1) ,  moderate (2) and 
intense (3) at high power  magnification. Area of epithelial staining was 
scored as 0 (0%). 1 (<25%), 2 (25-49%), 3 (50-74%) and 4(75-100%) 
by scanning the entire section. Colon cancer was taken as positive 
control (Figure 4) .   
 
In the normal tissues, β -catenin  staining was observed along the 
cell membrane of basal,  parabasal and spinous layer of surface 
epithelium (Figure 5).  Staining was not evident in stratum corneum.  A 
score of 3 was given for the staining intensity for all the normal 
tissues.   Almost al l the normal tissue showed more than 75% area of 
stain uptake by epithelial cells, thus a score of 4 was given excepting 3 
cases for which a score of 3 was given.  
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Membranous expression of β -catenin was found in well  
differentiated carcinomas (Figure 6 ).  Cytoplasmic localization was 
evident in few slides. Three cases showed mild staining , three cases 
showed moderate staining, Intense stain was observed in 4 cases.  The 
area of staining was found to be < 25% in two cases. 25-49% in 2 
cases, 50-74% in 4 cases and > 75% in 2 cases.  
 
In  moderately differentiated carcinoma (Figure 7) 4 cases 
showed intense staining, 3 cases showed moderate staining, 2cases 
showed mild staining and  2 cases showed no staining at  all .  Area of 
staining  was scored as 4 for 3 cases, 3 for 2 cases,  2 for 3  cases and 0 
for 2 cases. In one case no staining was evident in  invaded islands 
(Figure 8).   
 
Comparison of staining intensity showed a significant difference 
between normal and well differentiated carcinoma and also between 
normal and moderately differentiated carcinoma. However,  no 
significant difference in staining intensity was found between well  
differentiated and moderately differentiated carcinoma (Table 2).  
 
Similarly comparison of area of staining showed a significant  
difference between normal and well differentiated carcinoma and also 
between normal and moderately differentiated carcinoma. However,  no 
significant difference in area of staining was found between well  
differentiated and moderately differentiated carcinoma (Table 3).  
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It  is evident that membranous expression of β -catenin is reduced  
in the case of malignancy compared to the normal tissues.  This is  
similar to the observation made by Lihong Wand et al  
3 3
,  Soichi Iwai 
et al  
3 4
,  Lai-Kui Liu et al  
3 5
,  S.Y. Chaw et al
5
 ,  Khaled Waleed Zaid 
et al 
9
.   
 
APC gene in association with GSK 3β (Glycogen Synthase 
Kinase)  causes degradation of  free β-catenin in the cytoplasm by 
phosphorylation
5 5
.   Mutation in APC gene / GSK 3β /  β-catenin  
phosphorylation si te will lead to increase in cytoplasmic accumulation 
of β catenin5 5 .  This facili tates β -catenin binding with T cell factor 1 -4 
and Lymphoid enhancer factor (Lef - 1) and  translocate to nucleus. 
This in turn activates   transcription  of  genes like c -myc, EGFR, 
urokinase type plasminogen activator receptor tissue proteases etc. . 
essential  for proliferation invasion
5 6 .  This explains why β -catenin was 
localized along the cell membrane in our normal epithelium.  
 
Wnt secrete l ipid modified signaling protein which binds to 
receptor molecules Frizzled protein and lipo protein receptor related 
protein 5 &6 (LRP-5/6). This leads to β -catenin accumulation in the 
cytoplasm. Absence of Wnt signaling  keep the levels of β -catenin low  
by its  degradation by APC. Activation of Wnt leads to inhibition of 
GSK -3 β and thereby APC activ ity thus there is    increased β -catenin 
in cytoplasm followed by   increased transcription in malignancy
5 7
.  
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This explains the shift in localization of  β -catenin from cell  
membrane to cytoplasm to nucleus in squamous cell carcinoma. The 
reason for  se lective nuclear expression of β -catenin in invading 
islands may be due to the following reason. The increased cytoplasmic 
β catenin levels leads to activate p53 gene activation 2 6 .  when other 
mechanism fail to contain the levels of  β -catenin in cytoplasm. When 
the neoplastic cells overcome this counter mechanism, β -catenin 
translocates to the  nucleus followed by transcription of genes related 
to tissue invasion,  proliferation and dedifferentiation of cells
, 5 7 ,5 8
.   
 
Thus membranous β -catenin expression is found in more 
differentiated cells while  cytoplasmic  & nuclear expression seen in 
less differentiated cells.  The basal,  para basal  and spinous layer 
expression  of  β-catenin in epithelium shows their role in maintaining 
tissue polari ty and architecture also.  
 
p53 is a tumor suppressor gene which protects the  cells from  
genotoxic stress by  preventing DNA damage.  It  activates genes p21 
which regulates G1 arrest  for DNA repair to occur or triggers apoptosis 
of cells,  in case of irreversible DNA damage. Thus it is consider as the 
guardian of genome. Suppression of P53 function by mutation will lead 
to carcinogensis
1 7 ,5 9
.  
 
Two homologues of p53 namely p63 and p73 have been 
identified. They share similar transcriptional activation domain, DNA 
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binding domain and oligomerisation domain similar to p53 (Figure 2),  
but contain an addit ional c -terminal extension that  is  not present in 
p53
5 9 ,6 0
.  They maintain cell  homeostasis by interacting with p53 target 
genes. p63 plays a role in ectodermal differentiation during 
embryogenesis
6 1
.  It  is  located on human chromosome 3q27 -29
5 9 ,6 2
.  
Alternative promoters and splicing si tes give rise to six different 
protein isoforms. The transactivating isoforms are TAp63α, TAp63β, 
TAp63γ. The truncated isoforms lack transactivating domain in N-
terminal and includes ∆Np63α, ∆Np63β, ∆Np63γ 5 9 ,6 3 .   
 
TAp63 has a role in female germ cell preservation, induces 
senescence, and protects against  cancer metastasis
6 4 .  ∆Np63 has a 
fundamental role to maintain stem and progenito r in stratified 
epithelial and glandular tissue. It exerts a negative effect on TAp63 
transcriptional activity by repressing TAp63 induced miRNA, thus 
inhibits senescence and promotes carcinogenesis
6 5
.  Inactivation or loss 
of TAp63 leads to metastatic and invasive phenotype. p63 isoforms  
regulate a wide range of target  genes with opposite regulatory 
outcomes
6 5
.  
 
p63 is regulated at mRNA level by RNA binding proteins like 
PCB1, HuR
5 9
.  Phosphorylation of p63 regulate its activation and 
degradation. Ubiquit in  E3 ligases,kinases are also known to regulate 
p63 stability
6 6 ,6 7
.  The  peptidyl –prolyl  cis/trans isomerase domain at C 
Discussion 
 
 Page 60 
 
–terminal confers conformational and functional changes of substrate 
proteins that  provides stability to the TAp63α isoforms 6 8 .  
 
TAp63 also regulates metabolism. During starvation of cells it  
activates glutaminase which converts glutamine to α -ketoglutarate and 
production of ATP via tri carboxylic acid cycle.  The increased 
glutaminase reduces the ROS levels with in cells. ∆Np63 regulates 
glutathaione peroxidase 2, an antioxidant Selenium protein which 
converts hydrogen peroxide to water. Thus isoforms of p63 play an 
important role in oxidative stress
6 5
.   
 
Loss of TAp63 leads to loss of p53 activity and promotes  
tumorigenesis.  Amplification of p63 genes has been observed in 80% 
of  HNSCC. p63 prevents epithelial mesenchymal transition by 
inducing mir200. It  also suppress metastasis by promoting sharp 1 
expression  which affects hypoxia induced  stability
6 9 ,7 0
.   
 
The role of p63, the newer homologue of p53 is not completely 
known. Hence we decided to study the expression of p63 in different 
grades of oral  squamous cell carcinoma using immunohistochemistry.  
 
In this study previously diagnosed 10 cases of well differentiated 
carcinoma and 11 cases of moderately differentiated carcinoma was 
selected. 15 normal tissue samples were selected as controls.  
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Immunohistochemical expression of p63 was analyzed based on the 
intensity of stain uptake and area of epithelial staining.  
 
As p63 is expressed in basal  cells  of normal prostate and absent 
in prostatic adenocarcinoma normal prostate has been taken as positive 
control (Figure 9).  
 
Intensity of staining was scored as nil  (0),  mild (1) ,  moderate 
(2) and intense (3) at  high power magnification. Area of epithelial  
staining was scored as 0 (0%). 1 (<25%), 2 (25 -49%), 3 (50-74%)  and 
4(75-100%) by scanning the entire section.  
 
In the normal tissues, nuclear expression of p63 was observed 
(Figure 10). Staining was not evident in stratum corneum.  A score of 3 
was given for the staining intensity for nine normal tissues and a score 
of two for six  normal tissues.  Six cases showed more than 75% area of 
stain uptake and was given a score of 4.  Six cases obtained a score of 
three and three case obtained a score of two.  
 
All cases of well  differentiated carcinomas showed intense 
nuclear stains and hence a score of 3 was given (Figure 1 1). The area 
of staining was scored as 3 for six cases, two for three cases and four 
for one case.   
 
Discussion 
 
 Page 62 
 
Eight cases of moderately differentiated carcinoma (Figure 12) 
showed intense nuclear stain and were given a score of 3.  Two cases  
showed moderate staining intensity and a score of 2 was given. One 
case showed mild staining and a score of one was given. The area of 
staining was found to be more than 75% in 4 cases. Three cases showed 
50-74% of staining. Three cases showed, less than 50% of staining and 
one case showed less than 25% of staining.  
 
Comparison of staining intensity did not show any significant 
difference between normal and well differentiated carcinoma, between 
normal and moderately differentiated carcinoma and also between well  
differentiated and moderately differentiated carcinoma (Table 5).  
 
Similarly comparison of area of staining showed no significant 
difference between normal and well differentiated carcinoma, between 
normal and moderately differentiated carcinoma and also between well  
differentiated and moderately differentiated carcinoma (Table 6).  
 
In all the slides the p63 expression was found in the basal and 
Spinous layer and it was absent in the corneal layer . Similar 
observations was made by Nylander et al  & Matheny et  al.  p63 
expression was also found in the basal cells  of invading islands  
however the central  keratin pearls were unstained (Figure 11). This 
shows that  p63 is associated with the basic proliferative pool and this 
basic property is retained in the invading islands. Also the observation 
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that i t  is evident in spinous layer reveals its  role in epithelial  
stratification. This explains why no difference was observed in the 
staining intensity and also in the area of staining in normal, well and 
moderately differentiated carcinomas in our study.  
 
From this we understand that p63 shows a strong nuclear  
expression both in normal and carcinomas.  
 
Thus we conclude that expression of both β -catenin and p63 can 
be used as a prognostic marker in oral  squamous cell carcinoma.  
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SUMMARY AND CONCLUSION  
 The aim of the study was to analyse the immunohistochemical 
expression of p63 and β -catenin  in different grades of oral   squamous 
cell carcinoma. A total of 21 samples of  squamous cell carcinoma and 
15 samples of normal mucosa were taken from the archival blocks. 
Immunohistochemical expression of p63 and β -catenin were studied by  
analysis of intensity and area of staining of these markers.  
From the present study  following conclusions were drawn:  
  Significant  difference exists in the intensity and area of staining 
of  β-catenin  between normal t issues and carcinoma.   
  No significant  difference exists in the intensity and area of 
staining of  β-catenin  between well and moderately differentiated  
carcinoma.   
  No significant  di fference exists in the intensity and area of 
staining of  p63 expression between any of the  study groups.  
 We conclude that  the reduced  expression of  β-catenin   and 
shift  in the localization from cell membrane to cytoplasm  and nucleus 
has a potential  to indicate malignant transformation in the tissues.  
 
 The nuclear expression of  p63 in normal and malignant tissues 
suggest  that  it  is  closely linked with  basal cells  and proliferative 
variant  and can be used as potential marker for early diagnosis of  
carcinoma irrespective of the differentiation status.  
  
 Thus we conclude that  both expression of  β -catenin and p63  can 
be used as a prognostic marker in oral  squamous cell carcinoma.  
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ANNEXURE - II  
OBSERVER SCORES 
 
S.NO 
β CATENIN  p63 
Intensity Area Intensity Area 
NORMAL 
1 3 4 3 4 
2 3 4 2 3 
3 3 4 3 4 
4 3 4 3 3 
5 3 3 2 2 
6 3 4 3 4 
7 3 4 2 3 
8 3 4 3 4 
9 3 4 3 3 
10 3 3 2 2 
11 3 4 3 4 
12 3 4 2 3 
13 3 4 3 4 
14 3 4 3 3 
15 3 3 2 2 
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WELL DIFFERENTIATED CARCINOMA 
1 1 1 3 3 
2 2 2 3 3 
3 3 3 3 3 
4 1 2 3 3 
5 3 4 3 4 
6 3 4 3 3 
7 3 3 3 2 
8 2 3 3 2 
9 2 3 3 3 
10 1 1 3 2 
MODERATELY DIFFERENTIATED 
CARCINOMA 
1 3 3 3 3 
2 3 4 3 3 
3 3 4 3 4 
4 3 4 3 3 
5 2 2 1 1 
6 2 2 3 4 
7 0 0 2 2 
8 0 0 3 2 
9 1 2 2 2 
10 1 1 3 4 
11 2 3 3 4 
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